Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 6/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | KDM1B | Q8NB78 | 2/20 | 0.36 |
| ▸ | HTR2C | P28335 | 4/20 | 0.35 |
| ▸ | HTR2B | P41595 | 4/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.34 |
| ▸ | HTR2A | P28223 | 2/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17275132 | 0.73 | MEN1 (0.37) | KDM1ACYP1B1CYP1A2KCNH2KDM1B | |
| SCHEMBL17275133 | 0.70 | KDM1A (0.43) | KDM1ACYP1B1CYP1A2SLC6A4SLC6A2 | |
| SCHEMBL19417358 | 0.69 | CYP1A2 (0.45) | CYP1B1CYP1A2 | |
| SCHEMBL29405395 | 0.69 | CYP1A2 (0.45) | CYP1B1CYP1A2 | |
| SCHEMBL29406732 | 0.69 | CYP1A2 (0.45) | CYP1B1CYP1A2 | |
| SCHEMBL30366558 | 0.69 | CYP1A2 (0.45) | CYP1B1CYP1A2 | |
| SCHEMBL2679177 | 0.69 | CYP1A2 (0.45) | CYP1B1CYP1A2 | |
| SCHEMBL3575204 | 0.69 | CYP1A2 (0.45) | CYP1B1CYP1A2 | |
| SCHEMBL3583212 | 0.68 | CYP1B1 (0.33) | CYP1B1CYP1A2 | |
| SCHEMBL16800979 | 0.67 | CYP1A2 (0.40) | CYP1B1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015179448-A1 | THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2015-11-26 | — | — | WO | disclosed |